Aurinia Pharmaceuticals (AUPH) Goodwill & Intangibles (2016 - 2026)

Aurinia Pharmaceuticals (AUPH) has 11 years of Goodwill & Intangibles data on file, last reported at $3.6 million in Q1 2026.

• Quarterly Goodwill & Intangibles fell 13.66% year-over-year to $3.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.6 million (down 13.66% YoY) and the FY2025 annual result came in at $3.8 million, down 13.64% from the prior year.
• Goodwill & Intangibles eased to $3.6 million in Q1 2026, from $3.8 million in the prior quarter.
• In the past five years, Goodwill & Intangibles ranged from a high of $7.9 million in Q1 2022 to a low of $3.6 million in Q1 2026.
• A 5-year average of $5.2 million and a median of $4.8 million in 2024 frame the typical range for Goodwill & Intangibles.
• Annual changes were most pronounced in 2022 — Goodwill & Intangibles fell 23.55% — and 2025, when it fell 12.44%.
• Tracing AUPH's Goodwill & Intangibles over 5 years: stood at $6.4 million in 2022, then retreated by 22.54% to $5.0 million in 2023, then retreated by 12.5% to $4.4 million in 2024, then retreated by 13.64% to $3.8 million in 2025, then decreased by 4.55% to $3.6 million in 2026.
• The last three Goodwill & Intangibles figures came in at $3.6 million (Q1 2026), $3.8 million (Q4 2025), and $3.9 million (Q3 2025), per Business Quant data.